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Abstract
Background: Hypertension remains one of the most common chronic conditions in the United
States leading to several health complications and immense financial burdens, yet it remains
grossly undertreated despite the availability of evidence-based treatment options. The 2017
guidelines from the American College of Cardiology and American Heart Association
recommended the use of home blood pressure monitoring with a telehealth component as an
adjunct to regular hypertension treatment; however, implementing this into practice can be
difficult depending on the setting, available resources, and the knowledge and skills of the
providers. Aims: The purpose of this investigation is to evaluate patient adherence of measuring
and logging blood pressure on the electronic medical record patient portal and the provider
offering feedback regarding treatment. A secondary aim is to evaluate blood pressure trends of
patients pre- and post-intervention. Methods: A retrospective and prospective study was
completed to evaluate patient and provider adherence to using the recommended home blood
pressure monitoring with telehealth transmission. The goal was for patients to take and log blood
pressure daily for a minimum of two weeks. The number of blood pressures used to assess
adherence was 12 blood pressures in a one-month period. The provider was expected to follow
up anytime within the month period. Change in systolic and diastolic blood pressure was also
assessed. Results: Nine patients met the inclusion criteria and all nine patients participated in the
telehealth intervention. Six (66.7%) were adherent and logged at least 12 blood pressures, seven
(77.8%) logged at least 11 blood pressures and two participants (22.2%) logged no blood
pressure measurements. Provider feedback was given to the seven participants (77.8%) who
logged data. All patients who logged blood pressure measurements were within goal or near goal
at the end of the intervention. Discussion/Implications: High levels of provider and patient
adherence to the intervention suggest this intervention was an acceptable and feasible

cointervention for the management of hypertension in the primary care setting and could be
successful for the other patients with hypertension in this clinic and beyond.
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Evaluating the Use of Telehealth to Manage Hypertension in the Primary Care
Problem Statement/Background/Significance
Uncontrolled hypertension remains a significant problem in the United States despite the fact
that in most patients, this condition can be well-managed with lifestyle changes and
pharmacological interventions. Untreated or undertreated hypertension can lead to devastating
health consequences including death and puts a heavy burden on the healthcare system (Centers
for Disease Control and Prevention [CDC], 2020). In 2020, almost one half of the adults in the
United States had a diagnosis of hypertension; this has increased from one third of adults in 2016
(CDC, 2016, 2020). Hypertension costs the U.S. about $131 billion each year from health care
services, medications and missed days of work (CDC, 2020). Hypertension increases the risk for
stroke and heart disease, the leading cause of death in the United States. Moreover, only about
one half of adults with hypertension have attained blood pressure control (CDC, 2016). Barriers
to successful management of hypertension include suboptimal medication dosage/therapy inertia
(lack of medication changes after initial diagnosis and treatment was developed), lack of patient
engagement, non-adherence to treatment recommendations and limited resources to educate
patients on lifestyle changes (Milani et al., 2016).
One factor that contributes to uncontrolled hypertension is under treatment or conservative
management of hypertension by providers. This occurs for several reasons. For example, Mu and
Mukamal (2016) found that some of these reasons may occur due to competing demands of
primary care providers, a growing number of clinical practice guidelines with conflicting
recommendations, and short clinic visits. Additional factors that may contribute to uncontrolled
hypertension include previous visits with well-controlled blood pressure, side effects from
medications, a patient’s informed decision declining the intensification of therapy and the
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initiation of lifestyle interventions. Mu and Mukamal (2016) found that in several ambulatory
clinics across diverse demographics, providers rarely intensified antihypertensive therapy for
patients with an elevated blood pressure. For a systolic blood pressure greater than 120 mm Hg,
only 11% of patients received treatment intensification (9.7 million out of a potential 88.4
million). A higher prevalence of intensification occurred for those with higher blood pressure. Of
those with a systolic blood pressure greater than 160 mm Hg, only 2.5 million out of 9.7 million
(25.2%) had treatment intensified. This indicates that patients with higher blood pressures were
more likely to receive intensification of therapy but mild to moderately elevated blood pressures
were not treated with such urgency. This potential treatment inertia can lead to devasting health
outcomes. Timely intensification of medication may help improve hypertension-related
morbidity and mortality nationwide (Mu & Mukamal, 2016). Recent research indicates that
treatment intensification improves hypertension management even with suboptimal adherence
with a reduction of cardiovascular events and deaths (Mu & Mukamal, 2016).
Chronic illnesses require patient engagement to achieve maximum benefit and control of the
condition. Patient engagement has been shown to be an indicator of high-quality care, lower cost,
and better health. This has been shown to be dose dependent, i.e., the higher the engagement the
better the outcomes (Kaplan et al, 2017). Telehealth can be used as an effective method to
facilitate patient engagement. The Centers for Medicare and Medicaid Services’ (CMS)
electronic health records (EHR) incentive program, “Meaningful Use” encourages the use of
health information technology to promote patient engagement and provide a better understanding
of their care (CMS, 2012).
Telehealth is a broad term used to define healthcare provided remotely. There are four types
of telehealth branches. Synchronous telehealth includes a video visit or live chat with the patient

9

and provider. Care is provided in real time. Remote patient monitoring (RPM) allows providers
to view data collected from the patient remotely, such as vital signs. This form of telehealth is
often recommended for patients with chronic conditions. Asynchronous telehealth, or store-andforward, allows the transmission of patient health information to another healthcare provider.
Mobile health, or mHealth, utilizes smart devices that can collect data about a person’s health
(e.g., heart rate, pulse ox, movement tracking and sleep cycles) to promote healthy behaviors
(Pennic, 2015). Often a combination of two or more types of telehealth are used to provide
remote healthcare to patients.
Out-of-office blood pressure monitoring is useful with a cointervention such as telehealth or
counseling to diagnose and manage pharmacological therapy of hypertension (Whelton, 2017).
The 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood
Pressure in Adults gave a Grade I recommendation for the use of out-of-office blood pressure
measurements to help confirm and titrate medications with telehealth counseling or clinical
interventions. An additional Grade IIA recommendation was given on the use of telehealth
strategies in addition to usual care intervention to reduce blood pressure in adults with
hypertension (Whelton et al., 2017). The effects of various telehealth interventions for lowering
blood pressure were significantly greater than blood pressure self-monitoring without
transmission suggesting the importance of the teletransmission approach and timelier provider
feedback. Telehealth has not been demonstrated to be an effective standalone strategy to manage
hypertension; however, telehealth with cointerventions has been shown to be an effective adjunct
in the management of hypertension (Whelton et al., 2017).
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Purpose/Objectives
In a Northern Kentucky community hospital primary care clinic, a physician champion
identified suboptimal control of hypertension as an important clinical problem. Specifically, the
issue of patients who present with elevated blood pressure in the office but report their blood
pressure is well controlled at home. This is reported as a common occurrence and presents a
clinical dilemma of whether or not to intensify pharmacological therapy. The goal of this project
was to develop and implement an evidence-based intervention to identify patients who have
controlled hypertension versus those who have truly elevated blood pressure requiring
intensification of pharmacological therapy and closer follow-up care. A preliminary review of
the literature revealed that out-of-office blood pressure with a component of telehealth can be
effective in managing hypertension. The goal was to pilot the implementation of home-blood
pressure monitoring with the transmission of data using the MyChart® application, which is
linked to Epic®, the electronic health records (EHR) system used by the facility, to assess
adherence to daily blood pressure monitoring and logging the data in the EHR and gauge the
potential feasibility of implementing this intervention.
The primary objective is to evaluate patient adherence to a regimen of taking and logging
12 blood pressures in a 4-week period on the application and the provider offering feedback
within that month regarding treatment. A secondary objective is to evaluate blood pressure trends
among patients pre- and post-intervention.
Theoretical Framework
The health belief model (HBM) was developed in the 1950s by social scientists at the
United States Public Health Service to understand people’s failure to adopt disease prevention
strategies or screening tests, factors that impact a person’s response to symptoms, and the
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barriers and facilitators of adherence with recommended treatment (Rosenstock, 1974; LaMorte,
2019). The six tenets of the HBM are perceived susceptibility, perceived severity, perceived
benefits, perceived barriers, cues to action and self-efficacy (LaMorte, 2019). The HBM suggests
that a person’s belief in the effectiveness of the recommended health behavior or action will
predict the likelihood that the person will adopt the behavior. The HBM assumes that individuals
have the desire to avoid illness, and the belief that a specific health action will prevent, or cure
illness will influence their associated health behaviors. An individual’s response often depends
on the person’s perception of the benefits and barriers of a health behavior (LaMorte, 2019).
This model was ideal for this project because of the nature of the intervention. Each tenet
of the HBM was addressed to help maximize patient adherence to the intervention (figure 1).
Home blood pressure monitoring and telehealth logging are largely patient dependent. Provider
education with the patient focused on the severity of the uncontrolled condition as well as the
long-term health effects. Patients might not fully understand the potential consequences of
untreated or undertreated hypertension as they might not have any symptoms. Also, the use of
the MyChart application allows a graph view (see Appendix A) for the patient to see how their
blood pressure is trending. This allowed the patient to have a visual representation of their health
which served as a cue to action. The education given by the physician champion focused on the
patient’s perceived severity of the illness. Discussing the benefits of gaining control of
hypertension with lifestyle changes and medication adherence was intended to help the patient
focus on perceived benefits of controlling their hypertension with the use of home blood pressure
monitoring and teletransmission of data. Education on how to perform the intervention, including
the logging of blood pressure with the MyChart application was provided by a clinical
pharmacist or medical assistant to help improve patient self-efficacy and self-management of
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hypertension. Blood pressure cuffs were also purchased by the clinic for patients to borrow, to
help negate some of the financial burden of purchasing a blood pressure cuff.
This intervention was performed in the patient’s home which helped alleviate the
potential barrier of setting up transportation and the financial cost of traveling to the clinic to
obtain blood pressure readings. Cues to action are the stimulus needed to trigger a behavioral
change (LaMorte, 2019). Patients might not perceive their blood pressure as a problem until the
topic is brought up by a healthcare provider. Provider education and recommendation of a
behavioral change acted as a cue to action. Seeing the trends and the improvement of logged
blood pressure acted as a cue to action to sustain the changed behavior. The provider education
helped address all six tenets of the health belief model to help the patients be successful with the
self-management component of their hypertension.
Review of Literature
Method
A literature review was conducted using PubMed, with search terms hypertension,
uncontrolled, telehealth, primary care, and mhealth. Additional filters for data retrieval included:
adults age 19+, English language and published between 2015 and 2020. Sixteen articles were
identified using these search criteria. Abstracts were reviewed for relevance; eight articles were
eliminated for irrelevance to the study topic. These included articles focused on diabetes and
chronic kidney disease. Two more articles were eliminated because they were clinical trial
protocols enrolling patients for future studies and had not collected data. Six articles were
selected and reviewed based on relevance to the topic.
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Synthesis of Evidence
Six articles were reviewed to assess the usefulness and feasibility of telehealth and
technology with home blood pressure monitoring. Pan et al. (2018), Buis et al. (2020) and
Sheppard et al. (2020) evaluated changes in clinic blood pressure pre- and post-home blood
pressure telemonitoring. A significant reduction in both systolic and diastolic blood pressure was
found in the intervention group. Even more significant was a high rate of adherence to the
intervention in the study by Pan et al. (2020) with 86.5% of participants in the intervention group
completing more than 70% of the required transmissions of their blood pressure reading.
Similarly, Buis et al. (2020) found that participants uploaded at least one blood pressure on 75%
of study days and 40.1% were fully compliant on days between baseline and follow-up.
According to a systematic review by Sheppard et al. (2020) patient self-monitoring was
associated with greater reduction in systolic blood pressure compared to usual care, regardless of
hypertension-related comorbidities at 12 months. High intensity interventions were more
effective than low intensity interventions in patients with obesity and stroke. High intensity
interventions included self-monitoring with an active intervention, including web based or
telephone tools to provide feedback, or self-monitoring with significant tailored support, from a
clinician or pharmacist indicating the importance of patient and provider engagement.
The Hyperlink trial conducted by Margolis et al. (2013) tested a 12-month intervention of
home blood pressure with telemonitoring with pharmacist management in adults with
uncontrolled hypertension which led to improved blood pressure control at six and twelve
months. Beran et al. (2018) evaluated what contributed to the Hyperlink trial’s success. Focus
groups from patients and an interview with the pharmacist found that the key components of
success were a strong patient/pharmacist relationship, individualized treatment plans and
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frequent contact with the pharmacist. The frequent check-in with the pharmacist allowed for
checkpoints to increase medication therapy and reinforce lifestyle modifications. Pan et al.
(2018) also found that participants in the intervention group were more likely to receive
medication changes than the control group, who received usual care (48.7% compared to 12.3%).
Additional benefits of home blood pressure monitoring with telehealth transmission were
increased patient awareness and involvement, as well as more data for the medical team which
improves communication and coordination (Pan et al., 2018).
Perceived benefits and burdens of the use of digital self-management intervention used
for reducing blood pressure were evaluated in a qualitative study conducted by Morton et al.
(2018). Participants were asked open-ended questions and seven themes were identified. Some
participants felt a benefit from seeing blood pressure readings, increased motivation for lifestyle
modifications, and the benefit of better health after seeing the effects of medication and lifestyle
changes. However, the participants also identified burdens of self-management including
worrying about health, uncertainty about whether the readings were representative, the burden of
making lifestyle changes and the burden of practicality (Morton et al., 2018). One limitation of
the study was that an assessment of psychological factors such as reassurance, anxiety and
uncertainty was not performed (Morton et al., 2018).
The reliability and accountability of patients to truthfully report blood pressures readings
without the use of automatic transmission may be a concern for providers when recommending
this type of intervention. However, this does not seem to be a clinically significant concern.
Parker et al. (2018) found a correlation of texted blood pressures having both an ending zero in
the systolic and diastolic blood pressure when compared to the automatic transmitted blood
pressure. This occurred less than 2% of the time and was not believed to be clinically significant.
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Another finding was the preference for a systolic blood pressure of 134 and diastolic blood
pressure of 84 when alert cut offs were 135/85. This occurred less than 4% of the time and was
also not thought to be clinically significant.
Identification of Knowledge Gap in Practice
The effectiveness of telehealth interventions and home blood pressure monitoring has
been established in the literature and is recommended in the 2017 guidelines from the American
College of Cardiology and the American Heart Association to reduce blood pressure in
hypertensive patients. What has not been well established is if this type of intervention works
better for some patient populations than for others. It is important to determine whether age,
technological experience, rural versus urban location or socioeconomic status affect the benefit
of the intervention. Different demographic factors are important components to adherence;
however, these were not evaluated in this investigation.
The guideline reports uncertainty about which combinations of telehealth interventions
work best such as auto transmission or, self-log. However, the key to success in all strategies was
the timely provider follow-up and individualized care.
Methods
Project Design
The project design was a retrospective and prospective study of patients who tracked
home blood pressure using the MyChart application from August 1, 2020 to March 1, 2021 at a
Northern Kentucky nonacademic community hospital primary care clinic. A chart review was
performed to extract data for evaluation.
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Setting
Agency Description
The project was implemented at a community hospital primary care clinic in Northern
Kentucky. There are four physicians working at the office. The physician champion typically
treats twenty-two to thirty patients a day with visit duration ranging from ten to twenty minutes.
Current workflow includes the medical assistant (MA) rooming patients and taking vital signs.
The MA first takes an automatic blood pressure. If this blood pressure is elevated, the MA will
then take a manual blood pressure. If this blood pressure is then elevated the MA will report the
reading to the physician champion and the blood pressure will be rechecked at the end of the
visit. Patients are currently being asked to use a paper log of blood pressures and bring it to each
visit for review with the provider.
Congruence of Project to Institutions Mission
The hospital uses the model ICARE, which stands for Innovation, Collaboration,
Accountability, Respect and Excellence to represent the core values of the healthcare institution.
This project was congruent with the values of innovation, collaboration, and excellence. The
project used technology as an innovative method to improve hypertension, a chronic condition,
by using creative solutions recommended by current evidence-based guidelines to promote
provider and patient accountability. The project used collaboration with the MD, Clinical
Pharmacist, MA, and information technology (IT). The aim of this project was to provide the
best care for the patient while encouraging patients and giving them the tools required to manage
their chronic medical conditions.
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Stakeholders and a Description of their Roles in the Project
The physician champion was a stakeholder in this project. The goal was to pilot the use
of home blood pressure monitoring with data transmission with the ultimate goal of the entire
practice utilizing telehealth management for improved blood pressure control. The physician
champion was responsible for ordering home blood pressure monitoring for patients, making
adequate adjustments to antihypertensive medication regimens and providing adequate follow up
for patients.
The MA was responsible for taking the initial blood pressure and subsequent blood
pressures as needed when the patient was roomed. The clinical pharmacist was responsible for
educating the patient how to accurately obtain a home blood pressure reading and how to log
blood pressure in the MyChart application. The administrative staff was responsible for setting
up patient appointments and ensuring follow-up. The information systems department provided
education to the physician on how to activate the blood pressure tracking feature on the MyChart
application and provided a tip sheet for patients to remind them of the steps of the process if
needed.
The patients were also stakeholders as hypertension is a chronic disease that requires
patient participation to successfully manage. Patient buy-in was crucial as they were responsible
for medication adherence and taking and recording their blood pressures.
Site-specific Facilitators and Barriers to Implementation
The CMS Meaningful Use Initiative requires the use of health information technology to
promote patient engagement and communication of care. Encouraging patient and provider
interaction as well as data transmission using the patient portal fills this measure. The clinic uses
Epic and strongly encourages patients to enroll in the patient portal, MyChart.
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Blood pressure control is a quality indicator measured at the clinic for each provider.
Gaining control of hypertensive patients who were previously uncontrolled would reflect
positively on the provider’s care making the providers more willing to partake in the
intervention.
Another facilitator is the national clinical quality measure (CQMS), the Merit-Based
Incentive Payment System (MIPS) from the CMS. The measure is to be submitted once per
performance period (12 months) for patients with diagnosed hypertension. The most recent
quality code is used to generate performance calculation. This creates national pressure to
adequately control hypertension (CMS, 2019).
As of 2020, providers are now able to bill for at home blood pressure monitoring creating
an additional financial incentive. The current procedural guidelines now have two new currently
procedural terminology (CPT) codes to support home blood-pressure monitoring (Berg, 2019).
This acts as a financial incentive for providers to order home-blood pressure monitoring. One
code will be for the initial education (99473) and the other code can be billed once a month for
ongoing treatment decisions of reviewing the blood pressures (99474). To bill for this code, 28
blood pressure readings over a 30-day period with a minimum of 12 readings is required and was
chosen as the minimum goal for blood pressures recorded in one month (Berg, 2019).
One of the largest barriers was achieving insurance coverage and patients obtaining blood
pressure cuffs for home use. Some insurance plans do not cover home blood pressure monitoring
devices therefore the patient would be expected to pay out-of-pocket for these monitors. The
price range could be as little as $20 to over $100. Allowing the patient to borrow blood pressure
cuffs at no cost helped negate the financial burden.
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Sample
The target population was adult patients over the age of 18 years of age with a known or
new diagnosis of hypertension whose blood pressure was not currently within goal range.
Inclusion criteria for patient participation were: adults 18 years and older, patients of the
physician champion, above goal blood pressure at office visit, MyChart activated, and having an
in-person appointment within the study period. Patients who met these criteria were approached
by the physician about performing the intervention (table 2). Those who were agreeable were
then given an order to check home blood pressure with telehealth transmission. The sample for
the study included all patients of the physician champion who were recommended to check blood
pressure at home and log the readings using the MyChart application.
Procedure
IRB Approval
The study protocol was reviewed and approved as an exempt application by two
institutional review boards at two separate institutions.
Description of Evidence Based Intervention
The evidence-based intervention assessed was the use of a telehealth strategy with home
blood pressure monitoring. This study aimed to assess patient adherence to taking and logging
home blood pressures using the MyChart application as well as adherence with provider followup of readings and possible interventions. Adults with out of goal blood pressure who met the
inclusion criteria were asked to check blood pressures at home and log the results in the MyChart
applications for a minimum of two weeks but could continue up to one month. Those who were
agreeable received education from the clinical pharmacist or MA on how to properly check
blood pressure using the device and how to log the data in the patient portal. An order was
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placed in Epic enabling the patient flowsheet, which allowed blood pressure readings to be
logged. Participants were asked to check blood pressure for a minimum of two weeks but could
continue up to four weeks. By the end of the four weeks the provider would contact the patient
via MyChart message to discuss plan of care such as to continue current therapy, increase
medication, decrease medication, continue home blood pressure checks or to schedule an office
visit. The follow up could be a telephone call, MyChart message, video visit or in person patient
visit. Thresholds for extremely elevated or low blood pressures were set based on patient
dependent risk and goals. Notifications would be sent through Epic to the provider if these
triggers were meant to allow for early feedback and interventions.
Measures and Instruments
Measurement of patient blood pressure was recorded by the patients to assess the blood
pressure trend. The number of blood pressures obtained by the patient in a two-week and fourweek period was evaluated as well as overall trends of systolic and diastolic blood pressure.
Follow up by the provider was assessed using the chart review tab in Epic. Provider follow-up as
well as intervention provided was assessed.
Data Collection
Data were collected by performing a chart review in Epic. The provider champion carbon
copied all participants who were asked to perform the intervention to the DNP student allowing
access to the medical chart. The data included the demographic data, blood pressures recorded by
patients over two and four weeks, the number of blood pressures taken in the given cycle, the
communication from the provider to the patient as well as documentation of the communication
from the provider to the patient. Data was stored in a password protected program, RedCap and a
password protected computer to ensure patient confidentiality.
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Data Analysis Plan
Descriptive statistics were used to analyze demographic data as well as data collected to
evaluate the intervention. Data was placed in tables and graphs using excel to identify trends in
the data.
Results
Nine patients met the inclusion criteria and were approached about participation in the
intervention. All nine patients approached were agreeable to participate in the intervention
during the data collection period. Complete demographic data is in table 2. Of the participants,
seven were male (77.8%) and two were female (22.2%). Age was well distributed between the
age of 25 to 75 years and older. All nine participants (100%) were Caucasian. Most participants,
five individuals, had some version of public health insurance (55.6%) while three had private
(33.3%) and one participant had no health insurance (11.1%). Six (66.7%) of the patients were
on hypertensive medication prior to the intervention. The majority of participants were classified
as obese (7, 77.8%) and had a comorbid diagnosis of hyperlipidemia (5, 55.6%). Most were
nonsmokers (6, 66.7%) and did not have a diabetes diagnosis (8, 88.9%)
Evaluation of patient adherence to the interventions found that six participants (66.7%)
completed a minimum of 12 blood pressures but only two participants (22.2%) completed 28
blood pressure measurements (figure 3 and 4). One participant (11.1%) had logged eleven blood
pressures over the period and two participants (22.2%) logged no data over the period. Of the
seven patients (77.8%) who completed any number of blood pressure logs, all participants
received feedback from the provider within four weeks (figure 7). Of the seven, four (57.1%)
were recommended to increase their medication, one was recommended to decrease medication
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(14.3%) and two (28.9%) were recommended to make no changes to their current medication
(figure 9).
A trend noting decrease in both systolic and diastolic blood pressure was noted when
each were plotted in a line graph. Participants who had medication dosages increased were noted
to have logged more blood pressure readings (figure 5 and 6) than those who did not have
medication increased. The trend of systolic and diastolic blood pressure indicates that all patients
had controlled or near controlled blood pressure by the end of the evaluation. Statistical analyses
were not possible due to the small sample sizes.
Discussion
This investigation found high rates of adherence to blood pressure monitoring and
logging as well as timely provider feedback. When looking at the primary objective of patients
and provider adherence to taking blood pressure and logging, both patient and provider had high
rates of adherences (figure 3 and 4). Overall patients were highly adherent to the intervention of
taking and logging blood pressure with seven of the nine (77.8%) participants logging any
amount of blood pressure and six (66.7%) logging the minimum of 12 blood pressures during the
data collection period. Only two participants (22.2%) logged at least 28 blood pressure readings
over the collection period. These results are consistent with other similar studies from Buis et al
(2020) and Pan et al (2018) who also found high rates of adherence to monitoring home blood
pressure and electronically logging blood pressure data.
This investigation found that younger participants were less likely to log blood pressure.
Age (35-44 years old) was the only similarity between the two participants who did not log any
blood pressure readings. This could have occurred for a variety of reason but may have occurred
due to the health behaviors of the age group. Younger, generally healthy individuals may not
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perceive elevated blood pressure as a concern. This is consistent with the results from Ma (2018)
which found age was associated with differing self-care behaviors; middle-aged adults had better
self-care behaviors than their younger counterparts. Future investigation should focus on age
based perceived susceptibility and severity to assess if this link exists. Of the two participants
with no logged blood pressures, one was male and on two antihypertensive medications and the
other was female not on any medications.
All patients who participated in the study were Caucasian. This, however, is reflective of
the population of the county of this primary care clinic. In 2019, 94% of the county population
was Caucasian and 3% was Black or African American (The United States Census Bureau,
2019). This may be indicative that the intervention might not be effective for other demographic
populations.
The wide range of ages of participants (table 3) of the study indicates that even with
requirement of a smart phone and internet connection this intervention would be feasible for all
ages. Technology did not likely play a large role in the intervention as patients were already
enrolled in MyChart and had access to the internet with a smartphone prior to the intervention.
Most patients are already enrolled in MyChart. Of the 2500 of the physician champions patients,
1932 (77.3%) are currently registered for the MyChart, indicating this intervention would be
appropriate for most patients.
All seven patients who logged blood pressure received feedback from the provider (figure
7). After the initial feedback using MyChart messages, a variety of methods were used including
additional MyChart messages, video visits and in person visits. A combination of methods were
used for some patients. Patients and providers appeared to favor some component of MyChart
messages which could indicate patients prefer this method because of the convenience of not
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having to schedule an appointment or travel as frequently. This investigation only assessed the
provider feedback within the month period but did not assess the time between provider feedback
and intervention. Future studies should exam the length of time between each interactions as well
as if those with higher levels of uncontrolled hypertension had more interaction between the
provider.
When discussing with the physician champion he noted the intervention was easy to use
and easily integrated into current clinic workflow. One benefit of the intervention was the blood
pressures were automatically integrated into the EHR. He noted that the intervention helps keep
patients accountable for their health but also helps to better guide treatment for these patients.
Changes in systolic and diastolic blood pressure was evaluated as well (figure 5 and 6). A
reduction of both systolic and diastolic blood pressure was noted from the beginning to the end
of the sample period. These results are consistent with prior studies from Pan et al. (2018), Buis
et al. (2020) and Sheppard et al. (2020) who found that self-monitoring with electronic logging
was an effective method to reduce systolic and diastolic blood pressure. It was noted that those
requiring medication increases had a greater reduction than those who did not require medication
increases. This was likely due to these participants having higher systolic and diastolic blood
pressures requiring medication intensifications which was then reflective in the blood pressure
after the medication changes were made. These participants also logged more blood pressures
which likely was a result of the change in the plan of care and the desire to see the change in
blood pressure readings. This investigation indicates that home blood pressure monitoring and
telehealth logging is a successful cointervention to usual care, however, it should be noted that
due to the small sample size statistical analyses could not be performed.
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This study did not evaluate the attitudes and feelings towards home blood pressure
monitoring with a telehealth component, however this is an important factor for patient
adherence. Morton et al., (2018) found that patients had mixed views on the use of self-blood
pressure monitoring. Some patients found a benefit of performing the intervention as they felt it
was beneficial to leading to better health and motivated them to make lifestyle changes. Other
participants felt a perceived burden to self-monitoring and logging as they worried about their
health. These attitudes and feelings toward the intervention may have been a contributor to
patient participation in this investigation and should be studies in future studies.
As a result of this investigation the physician champion has continued this intervention
on other hypertensive patients to use this as a cointervention to usual care. He plans to share data
collected from his patients as well as provide education on how to implement home blood
pressuring measurement with a telehealth component. The ultimate plan is to implement this
intervention office wide to all providers.
Implications
This pilot study shows promising evidence to suggest that the use of telehealth
intervention in addition to usual care can be effectively implemented with high levels of patient
and provider adherence for the management of hypertension in this clinical setting.
Implementation of this intervention practice wide would likely be beneficial however conducting
a longitudinal study with a much larger sample size would yield more robust evidence regarding
patient and provider adherence to the intervention as well as changes in blood pressure. Future
investigations should also focus on long-term control of patient blood pressure in clinic. Further
evaluation on different demographic variables such as age and gender, financial status and
educational background as it applies to adherence to the intervention may be beneficial to
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determine if certain education techniques work better for different populations. This
investigation did not assess these factors. Further assessment of patient and provider preference
on preferred feedback would be helpful in determining telehealth strategies to ensure tailored
intervention and sustained patient engagement.
Future studies should focus on patient and provider attitudes toward the intervention to
determine potential barriers to the use of home blood pressure monitoring with a telehealth
component. This would help with understanding widespread application of the intervention to
different clinical settings.
Limitations
Several limitation to this study can be identified. First, the small sample size of the
participants. All nine patients approached were agreeable to participate. Due to the small sample
size inferential statistics could not be used to detect significance. The small sample may not be
reflective of a larger population of patients. This study only evaluated Caucasian individuals and
may not be reflective of other population groups. Contributing factors to the small sample size
include using patients of only one provider and the COVID-19 pandemic. During the pandemic
patients may have opted not to have in-person visits or follow-ups and the length of recruitment
and may have favored video visits. Due to one of the pieces of inclusion criteria being the initial
visit being in person this may have eliminated potential participants to the study.
Secondly, the Hawthorne effect may also have contributed to the high amount of patient
adherence. Patients were aware that the provider was closely observing their blood pressures
which may have increased patient adherence to measuring and logging blood pressures as well as
medications and lifestyle changes which would have reflected in the blood pressure readings.
Also, the number of blood pressures logged may have been increased because of the same effect.
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However, Sheppard et al. (2020) found sustained blood pressure control at 12 months with the
home blood pressure measurement and telehealth logging suggesting that this intervention is
sustainable. Future longitudinal studies should focus on the sustained control of blood pressure in
these patients at each clinical visit.
Thirdly, only patients with uncontrolled hypertension were included. It would have been
beneficial to include all patients who had a diagnosis of hypertension to evaluate out of office
control of blood pressure.
Conclusion
Hypertension is a treatable chronic condition but has high levels of suboptimal control
nationwide (CDC, 2020). Uncontrolled hypertension can lead to high levels of mortality,
morbidity and financial strain in the U.S. Several factors contribute to low levels of control
including overly conservative treatment by providers, lack of patient engagement but also
patients reporting out of office control of blood pressure (CDC, 2020). Patient’s reportingcontrolled blood pressure at home creates a clinical dilemma. The goal of this investigation was
to implement an evidenced based intervention to assess blood pressure control to help guide
treatment. The published evidence and clinical practice guidelines make recommendations to use
home blood pressure monitoring with a telehealth component to increase patient engagement and
out of office blood pressure measurements to direct care of hypertensive patients. A retrospective
and prospective study was completed to evaluate the primary objective of assessing patient and
provider adherence to the intervention as well as the secondary objective of improvement of
systolic and diastolic blood pressure. Nine patients participated in the study with high levels of
both patient and provider adherence to the intervention. The trend of systolic and diastolic blood
pressure appeared to improve through the sampling period. High levels of provider and patient
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adherence to the intervention as well as improved systolic and diastolic blood pressure suggest
this intervention was an acceptable and feasible cointervention for the management of
hypertension in the primary care. Further research should be done with larger sample sizes to
confirm these results, assess the effects of different demographic variables as well as to evaluate
patient and providers feelings toward the intervention.
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Tables
Table 1
Inclusion and Exclusion Criteria
Inclusion Criteria
Adults 18 and older
Patients of the physician champion
Above goal BP at office visit
MyChart activated
Appointment within study period
Initial in-person visit

Exclusion Criteria
Blood pressure within goal
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Table 2
Descriptive summary of participant characteristics (N = 9)
Characteristics
n (%)
Age
18-24 years old
0 (0%)
25-34 years old
1 (11.1%)
35-44 years old
2 (22.2%)
45-54 years old
2 (22.2%)
55-64 years old
1 (11.1%)
65-74 years old
2 (22.2%)
75+ years old
1 (11.1%)
Sex
Male
7 (77.8%)
Female
2 (22.2%)
Ethnicity
White
9 (100%)
Hispanic or Latino
0 (0%)
Black or African American
0 (0%)
Native American or American Indian
0 (0%)
Asian/Pacific Islander
0 (0%)
Type of Health Insurance
Private
3 (33.3%)
Public
5 (55.6%)
No Insurance
1 (11.1%)
Marital Status
Single, never married
0 (0%)
Married or domestic partnership
8 (88.9%)
Widowed
0 (0%)
Divorced
1 (11.1%)
Separated
0 (0%)
Smoker
Yes
3 (33.3%)
No
6 (66.7)
Diabetic
Yes
1 (11.1%)
No
8 (88.9%)
Hyperlipidemia
Yes
5 (55.6%)
No
4 (44.4%)
Obesity
Yes
7 (77.8%)
No
2 (22.2%)
Hypertensive Medication Prior
Yes
6 (66.7%)
No
3 (33.3%

35

Figures
Figure 1
Health Belief Model as it Pertains to Home Blood Pressure Monitoring with Telehealth

Figure 2
Project Design
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Figure 3
Number of Blood Pressures Logged at 2 and 4 Weeks
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Figure 4
12 Blood Pressures Logged
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Figure 5
Systolic Blood Pressure
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Figure 6
Diastolic Blood Pressure
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Figure 7
Provider Feedback
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Figure 8
Type of Follow Up
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Figure 9
Medication Adjustments
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Appendix A

Patient view of logged blood pressure in the mobile MyChart
application

40

Appendix B
Citation:
Pan F, Wu H, Liu C, Zhang X, Peng W, Wei X, Gao W. Effects of home telemonitoring on the control of high blood pressure: a randomised control trial in the Fangzhuang Community
Health Center, Beijing. Aust J Prim Health. 2018 Nov;24(5):398-403. doi: 10.1071/PY17187. PubMed PMID: 30131099.
Objectives
Methods:
Outcomes
Sample
Results/Findings
Strength/Weaknesses
Evaluate the effect of home blood
RCT
Average change in
Intervention: n=52
-86.5% in the intervention group completed more than -Small sample size
pressure monitoring with telehealth
BP
Control: n= 55
70% of required data transmission.
-Not blinded
transmission on the control of high
BP estimates on day
-Medication changes 48.7% vs 12.3%
-Potential Hawthorne
blood pressure
30, 90 and 180
-Greater reduction in blood pressure compared to
effect
control
-Long term effect not
-Intervention greater reduction of BP
known
-Higher use of app greater reduction
-Increases patient awareness and involvement
-Provides the medical team more data increasing
medication changes
-Improves communication and coordination
Citation:
Buis LR, Roberson DN, Kadri R, Rockey NG, Plegue MA, Danak SU, Guetterman TC, Johnson MG, Choe HM, Richardson CR. Understanding the Feasibility, Acceptability, and
Efficacy of a Clinical Pharmacist-led Mobile Approach (BPTrack) to Hypertension Management: Mixed Methods Pilot Study. J Med Internet Res. 2020 Aug 11;22(8):e19882. doi:
10.2196/19882. PubMed PMID: 32780026; PubMed Central PMCID: PMC7448180.
Objectives
Methods:
Outcomes
Sample
Results/Findings
Strength/Weaknesses
Investigate the feasibility,
Mixed
Primary Outcomes:
N=15
-40.1% were fully compliant on days between
-Requires technology
acceptability and preliminary
method pilot -change in BP
baseline and follow-up.
-Small sample size
effectiveness of BPTrack (a clinical
study with a -Utilization of the
-After 12 weeks significantly reduce in SBP and DBP
pharmacist-led intervention that
12-week pre BPTrack app
-Patient perceived it as effective
incorporates patient and clinician
post
-Medication reminder did not improve adherence
facing apps to make electronically
intervention Secondary
-Patients uploaded at least one blood pressure
collected, patient generated data
Outcomes:
measurement on 75% of study days
availability to providers in real time
-change in
-Reduction of SBP and DBP
for HTN management. App includes
medication
-BPTrack was a feasible option for primary care
medication reminders.
adherence
-Aimed to understand barriers to
adoption and areas for improvement
identified by key stakeholders in
improve widespread application
Citation:
Sheppard JP, Tucker KL, Davison WJ, Stevens R, Aekplakorn W, Bosworth HB, Bove A, Earle K, Godwin M, Green BB, Hebert P, Heneghan C, Hill N, Hobbs FDR, Kantola I, Kerry
SM, Leiva A, Magid DJ, Mant J, Margolis KL, McKinstry B, McLaughlin MA, McNamara K, Omboni S, Ogedegbe O, Parati G, Varis J, Verberk WJ, Wakefield BJ, McManus RJ. Selfmonitoring of Blood Pressure in Patients With Hypertension-Related Multi-morbidity: Systematic Review and Individual Patient Data Meta-analysis. Am J Hypertens. 2020 Mar
13;33(3):243-251. doi: 10.1093/ajh/hpz182. PubMed PMID: 31730171; PubMed Central PMCID: PMC7162426.
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Objectives
Examine whether selfmonitoring can reduce
clinic BP in patients with
hyper-tension related comorbidities

Methods:
Systematic
review of
Medline,
Embse and
Cochrane
Library of
selfmonitoring of
BP were
selected and
individual
patients were
requested

Outcomes
Primary Outcomes:
-Change in clinic BP
between baseline and 12
months by number of
comorbidities
Secondary Outcomes:
-likelihood of
uncontrolled BP at 12
months by number of
comorbidities
Outcomes were also
accessed at 6 months

Sample
26 trials between
2005-2016
10,713
participants
Primary outcomes
were available in
16 studies and
7,360 of which
6,522 had
completed

Results/Findings
Self-monitoring was associated with reduced clinic SBP
compared to usual care at 12 month follow up regardless of
comorbidities
-Intense intervention were more effective than low intensity
intervention in patients with obesity a possibly stroke but this
effect was not observed in patients with CAD, DM or CKD
-Self monitoring was found to be effective at lowering BP
regardless of number of comorbidities
-cointerventions include self-management, pharmacist
support, tailored education and lifestyle counseling

Strength/Weaknesses
-Largest IPD metaanalysis of trials
examining the efficacy
of self-monitoring of BP
in HTN patients with a
HTN related comorbidity
-Unable to collect data
from all related studies

Citation:
Morton K, Dennison L, Bradbury K, Band RJ, May C, Raftery J, Little P, McManus RJ, Yardley L. Qualitative process study to explore the perceived burdens and benefits of a digital
intervention for self-managing high blood pressure in Primary Care in the UK. BMJ Open. 2018 May 8;8(5):e020843. doi: 10.1136/bmjopen-2017-020843. PubMed PMID: 29739782;
PubMed Central PMCID: PMC5942415.
Objectives
Methods:
Outcomes
Sample
7 Themes
Strength/Weaknesses
Explore perceived
Qualitative
Benefits and burdens of
N=35
1) Benefit of reassurance from seeing BP readings
Strengths:
burdens and benefits for
study
home monitoring
-Reassurance when BP readings are well controlled
-relatively open
patients using a digital
-Reassurance from keeping an eye on BP
questions
self-management
2) Benefit of motivation for lifestyle change from seeing BP
-Wide range of
intervention for reducing
readings
controlled and
high BP
-Seeing BP readings motivated lifestyle change
uncontrolled HTN
3) Benefit of better health
Further understand how to
-Perceived health improvement from medication changes
Limitation:
best capture burdens and
-Intervention can facilitate management of side effects
-Repeated interview may
benefits when evaluating
4) Burden of worrying about health
have been helpful
health interventions
-Negative emotional responses to seeing high readings
-Did not assess
-Worrying about medication change affecting health
psychological factors
5) Burden of uncertainty from self-monitoring
such as reassurance,
-Uncertain about whether readings are representative
anxiety or uncertainty
-Uncertainty about what to do about high or low readings
6) Burden of thinking about making lifestyle changes
-Worry or guilty about not engaging with healthy changes
7) Burden of the practicalities of adhering to intervention
procedures
-Buren of fitting self-monitoring into schedule
Citation:
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Beran M, Asche SE, Bergdall AR, Crabtree B, Green BB, Groen SE, Klotzle KJ, Michels RD, Nyboer RA, O'Connor PJ, Pawloski PA, Rehrauer DJ, Sperl-Hillen JM, Trower NK,
Margolis KL. Key components of success in a randomized trial of blood pressure telemonitoring with medication therapy management pharmacists. J Am Pharm Assoc (2003). 2018
Nov - Dec;58(6):614-621. doi: 10.1016/j.japh.2018.07.001. Epub 2018 Aug 1. PubMed PMID: 30077564; PubMed Central PMCID: PMC6727963.
Objectives
Methods:
Outcomes
Sample
Results/Findings
Strength/Weaknesses
The Hyperlink trial tested MixedMixed-methods analysis
228 intervention
The original study showed improvement in both SBP and
not known
a 12-month intervention
methods
of process of care data,
patient of the 450 DBP
of home blood pressure
analysis of
patient focus groups and
were examined. 5
telemonitoring with
process of
pharmacist interviews
patient focus
4 Themes Identified:
pharmacist case
care data,
groups and 4
-Relationship between patient and pharmacist
management in adults
patient focus
pharmacist
-Individual Treatment plan
with uncontrolled
groups and
interviewed
-Communication between clinical staff
hypertension. The
pharmacist
-Importance of frequent phone contact with pharmacist
intervention resulted in
interviews
improved BP control
BP control was achieved in 3 months in many patients
compared with usual care
-Key components of the intervention success were use of
at both 6 and 12 months.
home monitor and frequent medication changes over the
The aim was to
phone
investigate factors
-Patient and pharmacist valued strong patient/pharmacist
contributing to
relationship and individualized treatment plans
intervention success
Citation:
Parker RA, Paterson M, Padfield P, Pinnock H, Hanley J, Hammersley VS, Steventon A, McKinstry B. Are self-reported telemonitored blood pressure readings affected by end-digit
preference: a prospective cohort study in Scotland. BMJ Open. 2018 Jan 31;8(1):e019431. doi: 10.1136/bmjopen-2017-019431. PubMed PMID: 29391369; PubMed Central PMCID:
PMC5878245.
Objectives
Methods:
Outcomes
Sample
Results/Findings
Strength/Weaknesses
To determine if there was Prospective
Compare BP readings
N1=44,000 BP
Compared with automatic transmission, texted BPs had a
Strength:
an apparent preference for cohort study
between the patient texts
from 1068
significantly higher proportion of occurrences of both SBP
-Large sample size
particular end digits and
and automaticand DBP having zero as an ending digit (less than 2%)
-control group
entries which were just
transmission systems
N2= 20,705
Preference for SBP 134 and DBP 84 when alert cut off was
below target BPs which
while taking into account BP from 199
135/85
might suggest evidence of
clustering of readings
End zero preferences for zero numbers and specific value
data manipulation
within patients
preferences for readings just below the alert threshold exist
among self-reported data.
This proportion is small and unlikely to be clinically
significant
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